These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30002675)

  • 21. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.
    Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F
    Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
    Vallerand IA; Lewinson RT; Farris MS; Sibley CD; Ramien ML; Bulloch AGM; Patten SB
    Br J Dermatol; 2018 Jan; 178(1):76-85. PubMed ID: 28542914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
    Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
    Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Isotretinoin and Antihistamine versus Isotretinoin Alone in the Treatment of Moderate to Severe Acne: A Randomised Control Trial.
    Pandey D; Agrawal S
    Kathmandu Univ Med J (KUMJ); 2019 Jan.-Mar; 17(65):14-19. PubMed ID: 31734672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment.
    Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL
    Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study.
    Rademaker M; Wishart JM; Birchall NM
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):747-54. PubMed ID: 23617693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial.
    Strauss JS; Gottlieb AB; Jones T; Koo JY; Leyden JJ; Lucky A; Pappas AA; McLane J; Leach EE
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):777-84. PubMed ID: 11050580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isotretinoin for acne vulgaris.
    al-Khawajah MM
    Int J Dermatol; 1996 Mar; 35(3):212-5. PubMed ID: 8655243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined effect of tranilast 8% liposomal gel on the final cosmesis of acne scarring in patients concomitantly treated by isotretinoin: prospective, double-blind, split-face study.
    Weinstein A; Koren A; Sprecher E; Zur E; Mehrabi JN; Artzi O
    Clin Exp Dermatol; 2020 Jan; 45(1):41-47. PubMed ID: 31260124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Oral Retinoids in Treatment of Acne Vulgaris With a Bioinformatics-Based Perspective of Personalized Medicine.
    Scott-Emuakpor R; Vuthaluru K; Nagre A; Jawed I; Patel PA; Sidhu HK
    Cureus; 2023 Apr; 15(4):e38019. PubMed ID: 37228537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and side effects of the acne drug, oral isotretinoin.
    Charakida A; Mouser PE; Chu AC
    Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized, split-face study of concomitant administration of low-dose oral isotretinoin with 30% salicylic acid chemical peeling for the treatment of acne vulgaris in Asian population.
    Ye D; Xue H; Huang S; He S; Li Y; Liu J; Wang Z; Zeng W
    Int J Dermatol; 2022 Jun; 61(6):698-706. PubMed ID: 35285944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment.
    Hasibur MR; Meraj Z
    Mymensingh Med J; 2013 Jan; 22(1):42-8. PubMed ID: 23416807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
    Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
    J Am Acad Dermatol; 2001 Aug; 45(2):196-207. PubMed ID: 11464180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin.
    Truchuelo MT; Jiménez N; Mavura D; Jaén P
    Actas Dermosifiliogr; 2015 Mar; 106(2):126-32. PubMed ID: 25306870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Oral Supplements and Topical Adjuvants for Isotretinoin-Associated Side Effects: A Narrative Review.
    Reyes-Hadsall S; Ju T; Keri JE
    Skin Appendage Disord; 2024 Feb; 10(1):1-9. PubMed ID: 38313565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.